|
DE19651443A1
(de)
|
1996-12-11 |
1998-06-18 |
Hoechst Ag |
Selbstverstärkende, pharmakologisch kontrollierbare Expressionssysteme
|
|
AU737727B2
(en)
|
1997-04-10 |
2001-08-30 |
University Of Southern California |
Modified viral surface proteins for binding to extracellular matrix components
|
|
CA2306443A1
(en)
|
1997-10-14 |
1999-04-22 |
Darwin Molecular Corporation |
Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
|
|
EP1914304A1
(en)
|
1998-10-14 |
2008-04-23 |
Darwin Molecular Corporation |
Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
|
|
US6743631B1
(en)
|
1998-03-17 |
2004-06-01 |
North Shore University Hospital Research Corporation |
Use of human serum resistant vector particles and cell lines for human gene therapy
|
|
GB9810999D0
(en)
*
|
1998-05-21 |
1998-07-22 |
Goken Joop |
Materials and methods relating to the expression of genes
|
|
US6490476B1
(en)
|
1999-10-14 |
2002-12-03 |
Cti Pet Systems, Inc. |
Combined PET and X-ray CT tomograph and method for using same
|
|
US6825033B2
(en)
|
2000-03-02 |
2004-11-30 |
University Of Southern California |
Mutated cyclin G1 protein
|
|
US20010046491A1
(en)
|
2000-03-23 |
2001-11-29 |
Valerie Kristoffer C. |
Tumor radiosensitization with mutant thymidine kinase in combination with a prodrug
|
|
US20050130132A1
(en)
|
2002-09-06 |
2005-06-16 |
Day Craig H. |
Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
|
|
WO2004041844A2
(en)
|
2002-10-30 |
2004-05-21 |
Rigel Pharmaceuticals, Inc. |
Cell cycle targets and peptides
|
|
US20070178066A1
(en)
|
2003-04-21 |
2007-08-02 |
Hall Frederick L |
Pathotropic targeted gene delivery system for cancer and other disorders
|
|
US20090123428A1
(en)
|
2003-04-21 |
2009-05-14 |
Hall Frederick L |
Pathotropic targeted gene delivery system for cancer and other disorders
|
|
US7815902B2
(en)
|
2003-07-09 |
2010-10-19 |
Henry Ford Health System |
Methods and compositions for cancer therapy using a novel adenovirus
|
|
CN1871034B
(zh)
|
2003-07-09 |
2011-07-06 |
亨利福特保健系统公司 |
用新型腺病毒治疗癌症的方法和组合物
|
|
US7632509B2
(en)
*
|
2005-07-19 |
2009-12-15 |
Biosante Pharmaceuticals, Inc. |
Methods to express recombinant proteins from lentiviral vectors
|
|
CA2643102A1
(en)
|
2006-03-21 |
2007-09-27 |
The Regents Of The University Of California |
A method for noninvasively and quantitatively monitoring therapeutic and diagnostic transgene expression induced by ex vivo and in vivo gene targeting in organs, tissues and cells
|
|
WO2008140961A2
(en)
|
2007-05-08 |
2008-11-20 |
The Government Of The U.S.A, As Represented By The Secretary, Department Of Health And Human Services |
Papillomavirus pseudoviruses for detection and therapy of tumors
|
|
WO2008156655A2
(en)
|
2007-06-15 |
2008-12-24 |
Genelux Corporation |
Vaccinia virus vectors encoding a sodium-dependent transporter protein for imaging and/or treatment of tumors
|
|
WO2009070636A2
(en)
|
2007-11-27 |
2009-06-04 |
Stanford University |
Engineered cells, imaging reporter gene/probe systems, and methods of imaging
|
|
US20090176260A1
(en)
|
2007-12-04 |
2009-07-09 |
Joseph Ching-Ming Wu |
Double-fusion human embryonic stem cells, methods of making double-fusion human embryonic stem cells, triple-fusion human embryonic stem cells, methods of making triple-fusion human embryonic stem cells, and methods of monitoring double-fusion human embryonic stem cells and triple-fusion human embryonic stem cells
|
|
US9296790B2
(en)
|
2008-10-03 |
2016-03-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for protein delivery
|
|
US9067964B2
(en)
|
2008-12-18 |
2015-06-30 |
Oligomer Sciences Ab |
Complex and method for enhancing nuclear delivery
|
|
KR101032871B1
(ko)
|
2009-07-10 |
2011-05-06 |
주식회사 바이오드 |
비엠피-2와 에이치에스브이-티케이 자살유전자를 동시에 포함하고 발현 할 수 있도록 하는 벡터와 이 벡터가 도입된 자가조절형 줄기세포 치료제
|
|
CN103339262A
(zh)
|
2010-10-28 |
2013-10-02 |
弗吉尼亚联邦大学 |
具有治疗作用的癌症成像：治疗诊断学
|
|
US9636381B2
(en)
|
2012-01-18 |
2017-05-02 |
Neumedicines, Inc. |
Methods for radiation protection by administering IL-12
|
|
JP2016524590A
(ja)
|
2013-03-14 |
2016-08-18 |
エペイウス バイオテクノロジーズ コーポレイション |
遺伝子療法適用のためのチミジンキナーゼ診断アッセイ
|
|
AU2016317936A1
(en)
*
|
2015-09-04 |
2018-03-08 |
Tocagen Inc. |
Recombinant vectors comprising 2A peptide
|
|
EP3390645B1
(en)
|
2016-02-23 |
2022-09-14 |
Salk Institute for Biological Studies |
Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
|
|
CA3049652A1
(en)
|
2017-01-10 |
2018-07-19 |
Intrexon Corporation |
Modulating expression of polypeptides via new gene switch expression systems
|
|
WO2018150345A1
(en)
*
|
2017-02-16 |
2018-08-23 |
De Vita Bio Life Sciences |
An expression vector
|
|
AU2018231190B2
(en)
*
|
2017-03-08 |
2023-05-25 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use
|
|
KR102702230B1
(ko)
|
2017-05-26 |
2024-09-03 |
에피센트알엑스, 인코포레이티드 |
트랜스진을 보유하는 재조합 아데노바이러스
|
|
ES3052818T3
(en)
|
2018-02-09 |
2026-01-14 |
Us Health |
Tethered interleukin-15 and interleukin-21
|
|
AU2020291946B2
(en)
*
|
2019-06-14 |
2026-08-06 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against PD-1 and methods of use thereof
|
|
JP2023548746A
(ja)
*
|
2020-10-13 |
2023-11-21 |
クリヤ セラピューティクス インコーポレイテッド |
サイトカインをコードする核酸を送達するためのウイルスベクターコンストラクトおよびがんを処置するためのその使用
|
|
KR20240099339A
(ko)
|
2021-10-25 |
2024-06-28 |
젠비보, 인크. |
치료제 전달을 위한 조성물 및 방법
|